Renalytix Plc
Renalytix Plc (RTNXF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Renalytix Plc (RTNXF), featuring income statements, balance sheets, and cash flow data.
Renalytix Plc (RTNXF) Income Statement & Financial Overview
Analyze Renalytix Plc’s RTNXF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $586000.00 | $535000.00 | $709000.00 | $459000.00 |
| Cost of Revenue | $550000.00 | $601000.00 | $480000.00 | $502000.00 |
| Gross Profit | $36000.00 | -$66000.00 | $229000.00 | -$43000.00 |
| Gross Profit Ratio | $0.06 | -$0.12 | $0.32 | -$0.09 |
| R&D Expenses | $1.06M | $2.22M | $3.23M | $2.79M |
| SG&A Expenses | $4.50M | $3.85M | $5.34M | $6.06M |
| Operating Expenses | $5.56M | $6.07M | $8.56M | $8.85M |
| Total Costs & Expenses | $6.11M | $6.67M | $9.04M | $9.35M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $60000.00 | $69000.00 | $108000.00 | $127000.00 |
| EBITDA | -$5.46M | -$6.07M | -$8.23M | -$8.76M |
| EBITDA Ratio | -$6.71 | -$11.34 | -$11.60 | -$15.49 |
| Operating Income | -$5.53M | -$6.14M | -$8.34M | -$8.89M |
| Operating Income Ratio | -$9.43 | -$11.47 | -$11.76 | -$19.37 |
| Other Income/Expenses (Net) | -$1.55M | -$1.61M | -$146000.00 | -$1.26M |
| Income Before Tax | -$7.07M | -$7.74M | -$8.48M | -$10.15M |
| Income Before Tax Ratio | -$12.07 | -$14.47 | -$11.96 | -$22.12 |
| Income Tax Expense | $1.53M | $0.00 | $4000.00 | $0.00 |
| Net Income | -$7.07M | -$7.74M | -$8.48M | -$10.15M |
| Net Income Ratio | -$12.07 | -$14.47 | -$11.97 | -$22.12 |
| EPS | -$0.05 | -$0.08 | -$0.09 | -$0.11 |
| Diluted EPS | -$0.05 | -$0.08 | -$0.09 | -$0.11 |
| Weighted Avg Shares Outstanding | $138.16M | $96.79M | $94.28M | $92.31M |
| Weighted Avg Shares Outstanding (Diluted) | $138.16M | $97.65M | $97.27M | $94.77M |
Over the last four quarters, Renalytix Plc's revenue moved from $459000.00 in Q1 2024 to $586000.00 in Q4 2024. Operating income in Q4 2024 was -$5.53M, with a strong operating margin of -943%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Renalytix Plc remained robust at -$5.46M, reflecting operational efficiency. Net income rose to -$7.07M, with an EPS of -$0.05. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan